BAKER BROS. ADVISORS LP

CIK 1263508 · last filed 2026-04-22

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$1.60B

Companies

25

Total Filings

93

Lifetime Open-Market Net

$3.38B

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
PRLD Director $4.49 $0 2 2026-04-22
BCYC Director 937,483 $4.05 $3.80M $0 1 2026-01-06
KALA 46,480 $2.63 $122.2K -$4.23M 1 2025-10-02
KYMR Director 534,134 $86.20 $46.05M $173.05M 2 2025-06-30
ACAD Director 39,468,841 $21.09 $832.40M $1.96B 10 2025-06-02
INCY Director 314,600 $108.53 $34.14M $1.09B 11 2025-04-02
IMCR Director 2,144,060 $28.96 $62.09M $143.96M 2 2025-03-19
BeOne Medicines Ltd. (BGNE) Delisted Director 136,517 $184.71 $25.22M -$1.48B 8 2024-12-10
KOD Director 15,316,021 $34.06 $521.66M $106.09M 4 2024-07-02
MDGL Director 179,279 $480.77 $86.19M $135.10M 3 2024-03-25
Atreca, Inc. (BCEL) Delisted 2,971,128 $0.15 $445.7K -$442.3K 1 2023-10-23
TCRX Director $0.91 $0 1 2023-06-15
Seagen Inc. (SGEN) Delisted Director 42,989,787 $228.74 $9.83B $955.17M 9 2022-05-17
KNSA Director $51.89 $0 2 2020-07-02
Neurogene Inc. (NLTX) Delisted Director $13.96 $0 1 2019-10-15
IGM Biosciences, Inc. (IGMS) Delisted Director 2,883,204 $1.27 $3.66M $301.82M 1 2019-09-20
Aceragen, Inc. (IDRA) Delisted Director 4,312,924 $7.22 $31.16M $45.50M 4 2019-07-03
GENOMIC HEALTH INC (GHDX) Delisted Director 7,641,248 -$413.77M 10 2019-06-18
HOOK 820,729 $1.15 $943.8K $50.00M 1 2019-04-23
Mirati Therapeutics, Inc. (MRTX) Delisted 10%+ Owner 2,372,355 $58.70 $139.26M $28.00M 2 2017-11-13
Neurogene Inc. (AQXP) Delisted Director 9,412,424 $170.50M 4 2017-05-09
BELLICUM PHARMACEUTICALS, INC (BLCM) Delisted 10%+ Owner 434,760 $0.07 $32.5K $8.00M 1 2017-03-28
Invitae Corp (NVTA) Delisted 10%+ Owner 734,261 $0.09 $65.4K $17.60M 1 2016-11-18
BCRX 10%+ Owner 1,680,147 $8.70 $14.62M -$65.62M 3 2016-08-16
SYNAGEVA BIOPHARMA CORP (GEVA) Delisted Director 0 $158.62M 2 2015-06-23

Recent Filings · Page 4 of 10

93 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2020-12-04 BeOne Medicines Ltd. (BGNE) Delisted Mixed −9,231,468 -$2.00B EDGAR
2020-09-08 KOD Buy (P) +1,937,874 $91.91M EDGAR
2020-07-17 BeOne Medicines Ltd. (BGNE) Delisted Grant (A) +87,505,080 $1.25B EDGAR
2020-07-02 KNSA Grant (A) $0 EDGAR
2020-05-28 INCY Mixed +15,396 $1.2K EDGAR
2020-03-18 Buy (P) +488,274 $40.04M
2019-10-15 Neurogene Inc. (NLTX) Delisted Grant (A) $0 EDGAR
2019-09-20 IGM Biosciences, Inc. (IGMS) Delisted Mixed +18,864,000 $301.82M EDGAR
2019-09-20 KOD Exer (X) +6 $0 EDGAR
2019-07-03 Aceragen, Inc. (IDRA) Delisted Grant (A) +23,712 $61.9K EDGAR
Showing 3140 of 93
Page 4 of 10
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.